Moderna Inc. said Monday its experimental flu shot showed positive results in a late-stage trial.   In a Phase 3 study, the ...

A recombinant flu vaccine (Flublok) contains no eggs and was recently approved for use in individuals aged 9 years or older ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

Researchers conducted a meta-analysis of 16 randomised clinical trials comparing inactivated high-dose (60 µg haemagglutinin antigen load per strain) and standard-dose (15 µg haemagglutinin antigen ...

The latest phase 3 win is a boost for Moderna’s attempts to create a flu/COVID combination vaccine. The company withdrew a filing for FDA approval for its combo candidate last month while it waited ...

Sep. 11, 2024 — Avian influenza A (H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas ...

The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.

The Arizona Department of Agriculture, working closely with the USDA detected a strain of avian influenza in milk in Maricopa ...

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The Arizona Department of Agriculture (AZDA) has confirmed a new detection of H5N1 avian influenza in milk from a Maricopa ...